Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Aclaris Therapeutics, Inc. | acrs-20171231ex211e8825c.htm |
| EX-32.1 - EX-32.1 - Aclaris Therapeutics, Inc. | acrs-20171231ex321ab80e7.htm |
| EX-31.2 - EX-31.2 - Aclaris Therapeutics, Inc. | acrs-20171231ex312d050a6.htm |
| EX-31.1 - EX-31.1 - Aclaris Therapeutics, Inc. | acrs-20171231ex3118e0cd2.htm |
| 10-K - 10-K - Aclaris Therapeutics, Inc. | acrs-20171231x10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-214384) and Form S-8 (No. 333-207434, No. 333-210379, No. 333-216703, No. 333-220149) of our report dated March 12, 2018 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 12, 2018